A Simple Scoring System for Predicting In-Hospital Mortality after Heart Valve Surgery in A Developing Country

  • Amiliana M Soesanto Dept. Cardiology and Vascular Medicine, Faculty of Medicine Universitas Indonesia/ National Cardiovascular Center Harapan Kita
  • Aron Husink Mayapada Hospital Tangerang
  • Novi Ariyanti Pasar Minggu Hospital
  • Melyana Asmuni Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia/ National Cardiovascular Center Harapan Kita
  • - Oktavia Lilyasari Dept. Cardiology and Vascular Medicine, Faculty of Medicine Universitas Indonesia/ National Cardiovascular Center Harapan Kita
  • Arinto Bono Adji Hardjosworo Cardiac Surgical Division, Department of Surgery, Faculty of Medicine, Universitas Indonesia/ National Cardiovascular Center Harapan Kita
Keywords: Heart valves, multiple; Cardiac, Statistics, risk analysis/modeling; Cardiac, Surgery, complications; Cardiac, Mitral valve replacement; Cardiac, Mitral valve repair; Cardiac, Aortic valve, replacement

Abstract

Background: Various scoring systems predict mortality after cardiac surgery, but not many were designed for specific valvular surgery. Developing countries have different characteristics of patients and conditions in cardiac centers compare to developed countries. We aimed to develop a simple scoring system for predicting in-hospital mortality after valve surgery and further validate the scoring system.

Methods: For developing the scoring system, the data was taken from the medical record of patient underwent valve surgery in 2012 - 2014, and for the validation study, it was from 2015 to 2016. The scoring system was developed using logistic regression models, then validated using calibration and discrimination analysis.

Result: For developing a scoring system, we recruited 1040 patients in the study. The in-hospital mortality rate was 68 (6.5%). Eight variables were incorporated, including; functional class, hypertension, previous open-heart surgery, impaired renal function, right ventricular dysfunction, emergent operation,  coronary artery bypass surgery, and tricuspid valve surgery. The mortality risk score has Hosmer Lemeshow (H-L) test p-value = 0.212; AUC = 0.813 (CI 95% = 0.758–0.867); and cut-off point of 5, predicting 14% risk of death (sensitivity 72.1%, specificity 75.3%). In the validation study, 789 subjects were recruited. The observed and predicted mortality were 8.6% and 11.9% respectively, with H-L test p-value = 0.169 and AUC 0.761 (95% CI; 0.702-0.821)

Conclusion: We have developed a simple scoring system for predicting in-hospital mortality after valve surgery. The mortality risk score was well-calibrated with a moderate discrimination value in the validation study.

Downloads

Download data is not yet available.

References

REFERENCES
1. Soesanto AM. Penyakit Jantung Katup di Indonesia: masalah yang hampir terlupakan. Indones J Cardiol. 2012;33(4):205-208. doi:10.30701/ijc.v33i4.20
2. Nashef SAM, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardio-thoracic Surg. 1999;16(1):9-13. doi:10.1016/S1010-7940(99)00134-7
3. Eacts CS, Germany CH, Rosenhek R, et al. 2017 ESC / EACTS Guidelines for the Management of Valvular Heart Disease The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology ( ESC ) and the European.; 2017. doi:10.1093/eurheartj/ehx391
4. Shahian DM, Blackstone EH, Edwards FH, et al. Cardiac surgery risk models: A position article. Ann Thorac Surg. 2004;78(5):1868-1877. doi:10.1016/j.athoracsur.2004.05.054
5. Nashef SAM, Roques F, Sharples LD, et al. Euroscore II. Eur J Cardio-thoracic Surg. 2012;41(4):734-745. doi:10.1093/ejcts/ezs043
6. O’Brien SM, Shahian DM, Filardo G, et al. The Society of Thoracic Surgeons 2008 Cardiac Surgery Risk Models: Part 2-Isolated Valve Surgery. Ann Thorac Surg. 2009;88(1 SUPPL.):S23-S42. doi:10.1016/j.athoracsur.2009.05.056
7. Shahian DM, Brien SMO, Filardo G, et al. The Society of Thoracic Surgeons 2008 Cardiac Surgery Risk Models : Part 3 — Valve Plus Coronary Artery Bypass Grafting Surgery. ATS. 2009;88(1):S43-S62. doi:10.1016/j.athoracsur.2009.05.055
8. Parolari A, Pesce LL, Trezzi M, et al. EuroSCORE Performance in Valve Surgery: A Meta-Analysis. Ann Thorac Surg. 2010;89(3):787-793.e2. doi:10.1016/j.athoracsur.2009.11.032
9. Barili F, Pacini D, Grossi C, Bartolomeo D, Alamanni F, Parolari A. Reliability of new scores in predicting perioperative mortality after mitral valve surgery. J Thorac Cardiovasc Surg. 2014;147(3):1008-1012. doi:10.1016/j.jtcvs.2013.06.042
10. Rosenhek R, Iung B, Tornos P, et al. ESC working group on valvular heart disease position paper: Assessing the risk of interventions in patients with valvular heart disease. Eur Heart J. 2012;33(7):822-828. doi:10.1093/eurheartj/ehr061
11. Verheul HA, van den Brink RBA, Bouma BJ, et al. Analysis of risk factors for excess mortality after aortic valve replacement. J Am Coll Cardiol. 1995;26(5):1280-1286. doi:10.1016/0735-1097(95)00303-7
12. Asimakopoulos G, Edwards MB, Brannan J, Taylor KM. Survival and cause of death after mitral valve replacement in patients aged 80 years and over: Collective results from the UK heart valve registry. Eur J Cardio-thoracic Surg. 1997;11(5):922-928. doi:10.1016/S1010-7940(97)01206-2
13. Bernstein AD, Parsonnet V. Bedside estimation of risk as an aid for decision-making in cardiac surgery. Ann Thorac Surg. 2000;69(3):823-828. doi:10.1016/S0003-4975(99)01424-1
14. Haddad F, Doyle R, Murphy DJ, Hunt SA. Right ventricular function in cardiovascular disease, part II: Pathophysiology, clinical importance, and management of right ventricular failure. Circulation. 2008;117(13):1717-1731. doi:10.1161/CIRCULATIONAHA.107.653584
15. Haddad F, Couture P, Tousignant C, Denault AY. The right ventricle in cardiac surgery, a perioperative perspective: I. anatomy, physiology, and assessment. Anesth Analg. 2009;108(2):407-421. doi:10.1213/ane.0b013e31818f8623
16. Malouf JF, Enriquez-Sarano M, Pellikka PA, et al. Severe pulmonary hypertension in patients with severe aortic valve stenosis: Clinical profile and prognostic implications. J Am Coll Cardiol. 2002;40(4):789-795. doi:10.1016/S0735-1097(02)02002-8
17. Melby SJ, Moon MR, Lindman BR, Bailey MS, Hill LL, Damiano RJ. Impact of pulmonary hypertension on outcomes after aortic valve replacement for aortic valve stenosis. J Thorac Cardiovasc Surg. 2011;141(6):1424-1430. doi:10.1016/j.jtcvs.2011.02.028
18. Mubeen M, Singh AK, Agarwal SK, Pillai J, Kapoor S, Srivastava AK. Mitral valve replacement in severe pulmonary arterial hypertension. Asian Cardiovasc Thorac Ann. 2008;16(1):37-42. doi:10.1177/021849230801600110
19. Rosenkranz S, Bonderman D, Buerke M, et al. Pulmonary hypertension due to left heart disease: Updated Recommendations of the Cologne Consensus Conference 2011. Int J Cardiol. 2011;154(SUPPL. 1):S34-S44. doi:10.1016/S0167-5273(11)70491-0
20. Gali N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2009;30(20):2493-2537. doi:10.1093/eurheartj/ehp297
21. Denault A, Deschamps A, Tardif JC, Lambert J, Perrault L. Pulmonary hypertension in cardiac surgery. Current cardiology reviews 2010;6(1):1-14 doi: 10.2174/157340310790231671[published Online First: Epub Date]|
22. Voelkel NF, Quaife RA, Leinwand LA, et al. Right ventricular function and failure: Report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation. 2006;114(17):1883-1891. doi:10.1161/CIRCULATIONAHA.106.632208
Published
2022-06-13
Views & Downloads
Abstract views: 448   
Full Text (PDF) downloads: 151   
How to Cite
Soesanto, A., Husink, A., Ariyanti, N., Asmuni, M., Lilyasari, - Oktavia, & Hardjosworo, A. (2022). A Simple Scoring System for Predicting In-Hospital Mortality after Heart Valve Surgery in A Developing Country. Indonesian Journal of Cardiology, 42(4), 126-136. https://doi.org/10.30701/ijc.1174